… urgent call for the discovery of new potential molecules or vaccines to fight SARS-CoV-2.
In … Such passive immunotherapy is capable of exerting both active inflammatory cytokines …

… Passive immunotherapy using plasma from recovering patients was considered a promising
option in the treatment of SARS-CoV-2 infections. The WHO and the FDA have permitted …

… Insights gained from bats, which exhibit minimal disease in response to SARS-CoV-2 …
on selecting the most appropriate immunotherapeutic agents and timing their administration…

COVID-19 is a contagious disease caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2). To fight this pandemic, which has caused a massive death toll around …

… SARS-CoV-2 with the host immune system and the potential for the development of appropriate
immunotherapy … aspects can also help in the discovery of biomarkers for diagnosis of …

… immunotherapy, driven by immunoinformatics and comparison homology sequencing
with SARS-CoV … In one of our recent studies, we serendipitously discovered that flagellin-mediated …

While antibodies garner the lion’s share of attention in SARS-CoV-2 immunity, cellular … ,
solution which identifies and targets immutable sequences in SARS-CoV-2, not just those which …

… acute respiratory syndrome coronavirus-2 (SARS-CoV-2), … the distinctive structural features
of SARS-CoV-2 S protein, its … researchers has unexpectedly discovered a key potentially “…

Therapeutic approaches to mitigate the severe acute lung injury associated with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have rapidly entered clinical …

… , and molecular components of SARS-CoV-2, along … SARS-CoV-2. All the above-mentioned
strategies, as well as the role of nanomedicine for the diagnosis and treatment of SARS-CoV…